EE05506B1 - Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks - Google Patents

Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks

Info

Publication number
EE05506B1
EE05506B1 EEP200100256A EEP200100256A EE05506B1 EE 05506 B1 EE05506 B1 EE 05506B1 EE P200100256 A EEP200100256 A EE P200100256A EE P200100256 A EEP200100256 A EE P200100256A EE 05506 B1 EE05506 B1 EE 05506B1
Authority
EE
Estonia
Prior art keywords
strogens
progestins
administration
delivery device
drug delivery
Prior art date
Application number
EEP200100256A
Other languages
English (en)
Estonian (et)
Inventor
Tommi@Markkula
Juha@Ala@Sorvari
Harri@Jukarainen
Matti@Lehtinen
Jarkko@Ruohonen
Original Assignee
Leiras@Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras@Oy filed Critical Leiras@Oy
Publication of EE200100256A publication Critical patent/EE200100256A/xx
Publication of EE05506B1 publication Critical patent/EE05506B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100256A 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks EE05506B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/190,606 US6063395A (en) 1998-11-12 1998-11-12 Drug delivery device especially for the delivery of progestins and estrogens
PCT/FI1999/000887 WO2000028968A1 (en) 1998-11-12 1999-10-26 Drug delivery device, especially for the delivery of progestins and estrogens

Publications (2)

Publication Number Publication Date
EE200100256A EE200100256A (et) 2002-12-16
EE05506B1 true EE05506B1 (et) 2012-02-15

Family

ID=22702031

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100256A EE05506B1 (et) 1998-11-12 1999-10-26 Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks

Country Status (30)

Country Link
US (1) US6063395A (cs)
EP (1) EP1128811B1 (cs)
JP (1) JP2002529493A (cs)
KR (1) KR100621426B1 (cs)
CN (1) CN1168439C (cs)
AR (1) AR021152A1 (cs)
AT (1) ATE267004T1 (cs)
AU (1) AU760302B2 (cs)
BG (1) BG65042B1 (cs)
BR (1) BR9915326B1 (cs)
CA (1) CA2351068C (cs)
CO (1) CO5271704A1 (cs)
CZ (1) CZ301609B6 (cs)
DE (1) DE69917477T2 (cs)
DK (1) DK1128811T3 (cs)
EE (1) EE05506B1 (cs)
ES (1) ES2221454T3 (cs)
HK (1) HK1041814B (cs)
HU (1) HU226113B1 (cs)
ID (1) ID29190A (cs)
IL (2) IL142523A0 (cs)
NO (1) NO332168B1 (cs)
NZ (1) NZ511216A (cs)
PE (1) PE20001041A1 (cs)
PL (1) PL194876B1 (cs)
PT (1) PT1128811E (cs)
RU (1) RU2226387C2 (cs)
SK (1) SK286730B6 (cs)
WO (1) WO2000028968A1 (cs)
ZA (1) ZA200103298B (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US7011841B2 (en) * 2000-03-24 2006-03-14 Mark B. Lyles High density porous materials
US20060110424A1 (en) * 2000-03-24 2006-05-25 Lyles Mark B Ceramic and metal compositions
WO2001085132A1 (en) * 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
JP2004506698A (ja) * 2000-08-23 2004-03-04 アクゾ・ノベル・エヌ・ベー ヒトに用いるためのテストステロンエステル製剤
DE20015416U1 (de) 2000-09-06 2000-12-14 Bachmann, Karl-Heinz, 78667 Villingendorf Intrauterine Vorrichtung mit einem oder mehreren Pharmakadepots und integrierten Stellmitteln zur Variation der Abgabedosis
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
ES2388731T5 (es) * 2002-03-27 2018-01-19 Warner Chilcott (Ireland) Limited Dispositivos de administración de fármacos mediante una matriz intravaginal
JP2006506385A (ja) * 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション 治療剤を小嚢内デリバリーするための方法およびシステム
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
US7803395B2 (en) 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US8541028B2 (en) 2004-08-04 2013-09-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP3566742A1 (en) 2005-10-13 2019-11-13 Synthes GmbH Drug-impregnated encasement
US8303536B2 (en) * 2007-08-30 2012-11-06 Sunstorm Research Corp. Implantable delivery device
ES2365552T3 (es) * 2007-11-22 2011-10-06 Bayer Oy Sistema de administración vaginal.
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
LT2249757T (lt) 2008-02-04 2017-09-25 Ferring B.V. Vientisi intravaginaliniai žiedai, apimantys progesteroną, ir jų gamybos bei panaudojimo būdai
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
AU2014214538B2 (en) 2013-02-06 2018-11-15 Mark SILLENDER Embryo transfer catheter and method
AU2014214537B2 (en) 2013-02-06 2019-01-03 Mark SILLENDER Therapeutic substance transfer catheter and method
EP3010560B1 (en) 2013-06-21 2020-01-01 DePuy Synthes Products, Inc. Films and methods of manufacture
CA2985717A1 (en) * 2015-05-13 2016-11-17 Bayer Oy A long acting drug delivery device and its use in contraception
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
KR20200059224A (ko) * 2017-09-27 2020-05-28 베이어 오와이 엘라스토머 매트릭스로부터의 치료 활성제의 방출을 변형시키는 방법
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
WO2023230619A1 (en) * 2022-05-26 2023-11-30 Insigna Inc. Prevention of estrus in sow and ruminants
US20230381197A1 (en) 2022-05-26 2023-11-30 Insigna Inc. Compositions for non-surgical prevention of boar taint and aggressive behavior

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
CH657779A5 (de) * 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
EP0230654B1 (en) * 1985-12-28 1992-03-18 Sumitomo Pharmaceuticals Company, Limited Sustained pulsewise release pharmaceutical preparation
IT8702928A0 (it) * 1987-07-22 1987-07-22 Alga Di Giudici Angelamaria & Friggitrice con cestello rotante secondo un asse orizzontale.
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
RU2091081C1 (ru) * 1990-04-02 1997-09-27 Дзе Проктер Энд Гэмбл Компани Абсорбирующая полимерная композиция
JPH07216233A (ja) * 1992-09-21 1995-08-15 Toray Dow Corning Silicone Co Ltd フルオロシリコーンゴム組成物
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens

Also Published As

Publication number Publication date
AU1048800A (en) 2000-06-05
BG65042B1 (bg) 2007-01-31
CN1168439C (zh) 2004-09-29
PL194876B1 (pl) 2007-07-31
CZ20011569A3 (cs) 2001-10-17
IL142523A0 (en) 2002-03-10
HUP0104037A2 (hu) 2002-04-29
BR9915326B1 (pt) 2013-10-22
NO332168B1 (no) 2012-07-09
AU760302B2 (en) 2003-05-08
CO5271704A1 (es) 2003-04-30
CZ301609B6 (cs) 2010-04-28
BG105501A (en) 2001-12-29
CA2351068C (en) 2008-09-02
SK5132001A3 (en) 2001-11-06
PL348113A1 (en) 2002-05-06
BR9915326A (pt) 2001-10-09
DE69917477D1 (de) 2004-06-24
NO20012047D0 (no) 2001-04-26
HK1041814B (zh) 2005-04-29
HUP0104037A3 (en) 2003-04-28
KR20010075700A (ko) 2001-08-09
ATE267004T1 (de) 2004-06-15
US6063395A (en) 2000-05-16
NZ511216A (en) 2002-09-27
IL142523A (en) 2006-06-11
EE200100256A (et) 2002-12-16
AR021152A1 (es) 2002-06-12
WO2000028968A1 (en) 2000-05-25
RU2226387C2 (ru) 2004-04-10
CA2351068A1 (en) 2000-05-25
ES2221454T3 (es) 2004-12-16
NO20012047L (no) 2001-06-28
EP1128811B1 (en) 2004-05-19
SK286730B6 (sk) 2009-04-06
KR100621426B1 (ko) 2006-09-13
PT1128811E (pt) 2004-09-30
DE69917477T2 (de) 2005-06-02
HK1041814A1 (en) 2002-07-26
ID29190A (id) 2001-08-09
DK1128811T3 (da) 2004-09-27
CN1326337A (zh) 2001-12-12
PE20001041A1 (es) 2000-10-14
EP1128811A1 (en) 2001-09-05
JP2002529493A (ja) 2002-09-10
HU226113B1 (en) 2008-04-28
ZA200103298B (en) 2001-10-25

Similar Documents

Publication Publication Date Title
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
ATE289500T1 (de) Ophtalmologische medikamentenzuführvorrichtung
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
DK1473003T3 (da) Lægemiddeladministrationsanordning
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
EE05123B1 (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
PT1221918E (pt) Administracao de drogas sub-tenon
NO20014035D0 (no) System for oral administrasjon av medikament
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
GB9809933D0 (en) Drug delivery device
FR2796287B1 (fr) Dispositif d'administration de medicament
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
EE05050B1 (et) Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci
ZA984649B (en) "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
AUPQ552200A0 (en) Device and method for anterior segment drug delivery
DK0996436T3 (da) Farmaceutiske formuleringr, der indeholder tungtoplöselige lægemiddelstoffer
AUPP854499A0 (en) Device and method for anterior segment drug delivery
AUPP670198A0 (en) Drug delivery device
DE69634569D1 (de) Medikamentenabgabevorrichtung
HK1032014A (en) Improved drug delivery device and methods therefor

Legal Events

Date Code Title Description
HC1A Change of owner name
HC1A Change of owner name

Free format text: FORMER NAME: SCHERING OY

MM4A Lapsed by not paying the annual fees

Effective date: 20171026